Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing
Coya Therapeutics, Inc. (NASDAQ:COYA) announced blood biomarker data from an investigator-initiated, 21-week, double-blind, ...
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...
Daily Mail5d
Losing weight on fat jabs like Mounjaro or Ozempic? Here's how you keep it off for good... Follow these 6 steps to make sure you don't put the kilos straight back on once you ...
With weight loss drugs such as Ozempic and Mounjaro seemingly able to melt the pounds away, you might well think you'll never need a 'diet plan' again. Alas, you'd be wrong. As a leading weight ...
Patients who took Ozempic 2.0 in clinical trial reveal its staggering results... and terrifying side effects
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
Weight loss jabs hit with stricter rules as people with eating disorders get online prescriptions
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Yahoo Style UK3d
What to know before considering weight loss jabs, as patients face further checks
or heart problems Mounjaro is available as a pre-filled injection pen that is to be injected under the skin of your stomach area, thigh or upper arm. The starting dose is 2.5mg once a week for four ...
pharmaphorum4d
Mounjaro and Zepbound shortages over, declares FDA
The shortage, which began in December 2022 for Mounjaro and extended to Zepbound ... Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match ...
pharmaphorum4d
Scotland first UK nation to clear Mounjaro use for obesity
Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients. The Scottish Medicines ...
Investing4d
S&P 500 (SPX)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Medscape4d
Effectiveness and Tolerability of Every-Other-Day Rosuvastatin Dosing in Patients with Prior Statin Intolerance
Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...
Official Charts Company5d
Official Albums Chart Update
Please note, the data displayed for this chart reflects the title's midweek position only, peak positions on this chart also relate to midweek chart positions. Official Albums Chart Update data ...